-
Man, KKC, Coghill, D, Chan, EW, Lau, WCY, Hollis, C, Liddle, E, Banaschewski, T, McCarthy, S, Neubert, A, Sayal, K, et al.
Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.
Translational Psychiatry
6(11)
:
e956 -e956
2016
view publication
-
Balia, C, Carucci, S, Donno, F, Coghill, D, Zuddas, A.
P.7.d.005 Do callous–unemotional traits modulate pharmacological treatment of aggression in children and adolescents with conduct disorder?.
European Neuropsychopharmacology
26:
s731
2016
view publication
-
Carucci, S, Romaniello, R, Lampis, A, Panei, P, Coghill, D, Zuddas, A.
P.7.d.006 Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project.
European Neuropsychopharmacology
26:
s731 -s732
2016
view publication
-
Romanos, M, Coghill, D, Gerlach, M, Becker, K, Holtmann, M, Döpfner, M, Banaschewski, T.
Check and Double Check - the Cochrane review by Storebo et al. (2015) is indeed flawed..
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
44(5)
:
336 -337
2016
view publication
-
Kovshoff, H, Banaschewski, T, Buitelaar, JK, Carucci, S, Coghill, D, Danckaerts, M, Dittmann, RW, Falissard, B, Grimshaw, DG, Hollis, C, et al.
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale.
Journal of Child and Adolescent Psychopharmacology
26(6)
:
537 -547
2016
view publication